Income Statement MedPacto, Inc.

Stocks

A235980

KR7235980000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-09-11			5-day change	1st Jan Change
2,750.00 ^KRW	-2.31%		-4.84%	-58.83%

08-13	MedPacto, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-13	MedPacto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

5ca61ebfb6798f5.DgNvb0-JzlDw_BAPvKHw2usAzTg51A81Bf1CY8ePTBU.PEUJOwq_iwTIjyl_jMaH6rRakkoNhE4FdrEaJYLbJ3ZWTTU5YvGHBcDKKA

Published financial data: MEDPACTO, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	-	-	-	-	3.9B
Total Revenues	-	-	-	-	3.9B
Cost of Goods Sold, Total	-	-	-	-	3.51B
Gross Profit	-	-	-	-	385M
Selling General & Admin Expenses, Total	4.61B	4.99B	4.43B	3.61B	4.05B
Provision for Bad Debts	-	52.76M	-5.9M	-9.1M	25.43M
R&D Expenses	24.55B	31.92B	24.16B	18.02B	10.14B
Depreciation & Amortization - (IS)	257M	208M	118M	135M	147M
Amortization of Goodwill and Intangible Assets - (IS)	31.76M	44.08M	49.36M	50.78M	67.21M
Other Operating Expenses	12.46M	31.21M	-	-	-
Other Operating Expenses, Total	29.46B	37.25B	28.75B	21.81B	14.43B
Operating Income	-29.46B	-37.25B	-28.75B	-21.81B	-14.04B
Interest Expense, Total	-7.77B	-9.62B	-493M	-91.94M	-117M
Interest And Investment Income	664M	1.32B	388M	1.69B	1.24B
Net Interest Expenses	-7.11B	-8.3B	-105M	1.6B	1.12B
Income (Loss) On Equity Invest.	-361M	-	-	-424M	-
Currency Exchange Gains (Loss)	-19.66M	25.05M	114M	-116M	-17M
Other Non Operating Income (Expenses)	19.28B	9.27B	64.07M	85.4M	199M
EBT, Excl. Unusual Items	-17.67B	-36.25B	-28.68B	-20.67B	-12.74B
Gain (Loss) On Sale Of Investments	627M	492M	-39.93M	526M	-47.37M
Gain (Loss) On Sale Of Assets	-	-	-5.93M	-	-23.57M
Other Unusual Items	-	-	-6.6B	-	-
EBT, Incl. Unusual Items	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Earnings From Continuing Operations	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Net Income to Company	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Net Income - (IS)	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Net Income to Common Incl Extra Items	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Net Income to Common Excl. Extra Items	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Per Share Items
Net EPS - Basic	-832.3	-1.71K	-1.66K	-598.04	-373.76
Basic EPS - Continuing Operations	-832.3	-1.71K	-1.66K	-598.04	-373.76
Basic Weighted Average Shares Outstanding	20.47M	20.97M	21.22M	33.68M	34.28M
Net EPS - Diluted	-832.3	-1.71K	-1.66K	-598.04	-373.76
Diluted EPS - Continuing Operations	-832.3	-1.71K	-1.66K	-598.04	-373.76
Diluted Weighted Average Shares Outstanding	20.47M	20.97M	21.22M	33.68M	34.28M
Normalized Basic EPS	-539.34	-1.08K	-844.78	-383.54	-232.31
Normalized Diluted EPS	-539.34	-1.08K	-844.78	-383.54	-232.31
Supplemental Items
EBITDA	-27.74B	-35.38B	-26.92B	-20.27B	-12.89B
EBITA	-29.31B	-37.07B	-28.58B	-21.68B	-13.96B
EBIT	-29.46B	-37.25B	-28.75B	-21.81B	-14.04B
EBITDAR	-27.72B	-35.34B	-26.9B	-20.25B	-12.87B
Normalized Net Income	-11.04B	-22.65B	-17.92B	-12.92B	-7.96B
Supplemental Operating Expense Items
Selling and Marketing Expenses	948M	1.01B	1.45B	1.02B	925M
General and Administrative Expenses	12.27M	9.85M	9.73M	7.99M	6.13M
Research And Development Expense From Footnotes	24.55B	31.92B	24.16B	18.02B	10.14B
Net Rental Expense, Total	19.38M	36.4M	15.09M	13.91M	13.63M
Imputed Operating Lease Interest Expense	3.82B	40.32M	1.81M	4.68M	6.98M
Imputed Operating Lease Depreciation	-3.8B	-3.92M	13.28M	9.23M	6.65M
Stock-Based Comp., SG&A Exp. (Total)	1.03B	1.03B	258M	-74.22M	549M
Total Stock-Based Compensation	1.03B	1.03B	258M	-74.22M	549M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	1.29B	360M	72.6B	15.01B	12B
Short Term Investments	120B	96.59B	-	40.47B	28.7B
Total Cash And Short Term Investments	122B	96.95B	72.6B	55.48B	40.7B
Accounts Receivable, Total	250	270	380	-140	1.64B
Other Receivables	393M	1.8B	844M	383M	195M
Notes Receivable	-	-	-	-	589M
Total Receivables	393M	1.8B	844M	383M	2.43B
Inventory	-	-	-	-	646M
Prepaid Expenses	382M	352M	99.2M	50.37M	50.81M
Other Current Assets, Total	3.74B	1.23B	1.61B	878M	1.15B
Total Current Assets	126B	100B	75.15B	56.79B	44.97B
Gross Property Plant And Equipment	6.34B	10.68B	7.99B	8.13B	11.14B
Accumulated Depreciation	-3.78B	-5.48B	-4.35B	-5.35B	-8.73B
Net Property Plant And Equipment	2.56B	5.2B	3.65B	2.79B	2.41B
Long-term Investments	3.38B	995M	626M	224M	-
Other Intangibles, Total	566M	438M	343M	228M	595M
Accounts Receivable Long-Term	270	290	260	-160	42.54M
Other Long-Term Assets, Total	747M	720M	704M	754M	647M
Total Assets	133B	108B	80.47B	60.79B	48.66B
Liabilities
Accounts Payable, Total	-	-	-	-	73.35M
Accrued Expenses, Total	230M	237M	183M	191M	193M
Short-term Borrowings	-	60.26B	-	-	-
Current Portion of Leases	190M	689M	741M	461M	599M
Other Current Liabilities	557M	5.43B	641M	724M	503M
Total Current Liabilities	978M	66.62B	1.56B	1.38B	1.37B
Long-Term Leases	-	2.42B	1.69B	1.48B	1.13B
Other Non Current Liabilities	88.83B	142M	137M	187M	186M
Total Liabilities	89.8B	69.19B	3.39B	3.04B	2.68B
Preferred Stock Redeemable	-	6.18B	6.18B	-	-
Total Preferred Equity	-	6.18B	6.18B	-	-
Common Stock, Total	10.26B	10.54B	16.79B	17.14B	17.14B
Additional Paid In Capital	141B	165B	233B	240B	241B
Retained Earnings	-108B	-144B	-179B	-199B	-212B
Comprehensive Income and Other	-11.16M	216M	242M	345M	338M
Total Common Equity	43.54B	32.32B	70.91B	57.74B	45.98B
Total Equity	43.54B	38.5B	77.09B	57.74B	45.98B
Total Liabilities And Equity	133B	108B	80.47B	60.79B	48.66B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.52M	21.08M	33.58M	34.28M	34.28M
ECS Total Common Shares Outstanding	20.52M	21.08M	33.58M	34.28M	34.28M
Book Value / Share	2.12K	1.53K	2.11K	1.68K	1.34K
Tangible Book Value	42.98B	31.88B	70.57B	57.51B	45.39B
Tangible Book Value Per Share	2.09K	1.51K	2.1K	1.68K	1.32K
Total Debt	190M	63.38B	2.43B	1.94B	1.73B
Net Debt	-121B	-33.58B	-70.18B	-53.54B	-38.97B
Debt Equivalent Oper. Leases	155M	291M	121M	111M	109M
Equity Method Investments, Total	1.38B	995M	626M	224M	-
Inventories - Finished Goods, Total	-	-	-	-	646M
Inventories - Others	-	-	-	-	-310
Machinery, Total	2.91B	3.8B	1.24B	1.05B	4.3B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	-17.04B	-35.75B	-35.32B	-20.14B	-12.81B
Depreciation & Amortization - CF	1.57B	1.69B	1.67B	1.42B	1.07B
Amortization of Goodwill and Intangible Assets - (CF)	151M	175M	167M	124M	84.93M
Depreciation & Amortization, Total	1.72B	1.87B	1.83B	1.54B	1.16B
(Gain) Loss From Sale Of Asset	-	-	5.93M	-	23.57M
(Gain) Loss on Sale of Investments - (CF)	-627M	-1.02B	-351M	-555M	-220M
(Income) Loss On Equity Investments - (CF)	361M	525M	390M	453M	267M
Stock-Based Compensation (CF)	2.74B	2.38B	1.04B	698M	1.06B
Provision and Write-off of Bad Debts	-	-	-5.9M	-9.1M	-
Other Operating Activities, Total	-11.45B	141M	6.3B	-223M	167M
Change In Accounts Receivable	-	-	-	-	-1.67B
Change In Inventories	-	-	-	-	-646M
Change In Accounts Payable	-	-	-	-	73.35M
Change in Other Net Operating Assets	-862M	2.25B	-193M	1.68B	-792M
Cash from Operations	-25.15B	-29.61B	-26.3B	-16.56B	-13.39B
Capital Expenditure	-757M	-878M	-101M	-314M	-91.25M
Sale (Purchase) of Intangible assets	-152M	-47.4M	-72.27M	-8.78M	-152M
Investment in Marketable and Equity Securities, Total	-76.78B	26.77B	96.95B	-39.91B	11.99B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-621M
Other Investing Activities, Total	-80.24M	-80.91M	-250M	-10	-100M
Cash from Investing	-77.77B	25.76B	96.53B	-40.24B	11.02B
Short Term Debt Issued, Total	35.49M	-	1B	-	-
Long-Term Debt Issued, Total	70B	-	-	-	-
Total Debt Issued	70.04B	-	1B	-	-
Short Term Debt Repaid, Total	-35.49M	-	-1B	-	-
Long-Term Debt Repaid, Total	-485M	-503M	-70.82B	-844M	-635M
Total Debt Repaid	-521M	-503M	-71.82B	-844M	-635M
Issuance of Common Stock	1.97B	3.4B	72.84B	-	-
Issuance of Preferred Stock	30B	-	-	-	-
Other Financing Activities, Total	34M	-	-15.02M	-	-
Cash from Financing	102B	2.9B	2.01B	-844M	-635M
Foreign Exchange Rate Adjustments	-2.78M	19.59M	5.92M	45.57M	-10.92M
Net Change in Cash	-1.4B	-933M	72.24B	-57.59B	-3.01B
Supplemental Items
Cash Interest Paid	-	-	1.42B	-	-
Cash Income Tax Paid (Refund)	100M	123M	-124M	138M	-116M
Levered Free Cash Flow	-23.45B	-21.3B	-20.38B	-11.21B	-10.49B
Unlevered Free Cash Flow	-18.59B	-15.29B	-20.07B	-11.16B	-10.42B
Change In Net Working Capital	2.03B	-6.02B	4.02B	-1.33B	3.1B
Net Debt Issued / Repaid	69.51B	-503M	-70.82B	-844M	-635M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	-19.19	-19.32	-19.1	-19.3	-16.04
Return on Total Capital	-36.86	-21.06	-19.81	-19.58	-16.35
Return On Equity %	-34.32	-87.16	-61.12	-29.88	-24.7
Return on Common Equity	-34.32	-94.25	-68.44	-31.31	-24.7
Margin Analysis
Gross Profit Margin %	-	-	-	-	9.88
SG&A Margin	-	-	-	-	103.93
EBITDA Margin %	-	-	-	-	-330.59
EBITA Margin %	-	-	-	-	-358.06
EBIT Margin %	-	-	-	-	-360.24
Income From Continuing Operations Margin %	-	-	-	-	-328.61
Net Income Margin %	-	-	-	-	-328.61
Net Avail. For Common Margin %	-	-	-	-	-328.61
Normalized Net Income Margin	-	-	-	-	-204.24
Levered Free Cash Flow Margin	-	-	-	-	-269.1
Unlevered Free Cash Flow Margin	-	-	-	-	-267.22
Asset Turnover
Asset Turnover	-	-	-	-	0.07
Fixed Assets Turnover	-	-	-	-	1.5
Receivables Turnover (Average Receivables)	-	-	-	-	4.75
Short Term Liquidity
Current Ratio	128.95	1.51	48.03	41.29	32.86
Quick Ratio	124.74	1.48	46.94	40.62	31.08
Operating Cash Flow to Current Liabilities	-25.73	-0.44	-16.81	-12.04	-9.78
Days Sales Outstanding (Average Receivables)	-	-	-	-	76.82
Long Term Solvency
Total Debt/Equity	0.44	164.62	3.15	3.36	3.75
Total Debt / Total Capital	0.43	62.21	3.05	3.25	3.62
LT Debt/Equity	-	6.29	2.19	2.56	2.45
Long-Term Debt / Total Capital	-	2.38	2.12	2.48	2.36
Total Liabilities / Total Assets	67.35	64.25	4.21	5	5.51
EBIT / Interest Expense	-3.79	-3.87	-58.29	-237.19	-119.72
EBITDA / Interest Expense	-3.57	-3.68	-54.58	-220.42	-109.86
(EBITDA - Capex) / Interest Expense	-3.67	-3.77	-54.78	-223.83	-110.64
Total Debt / EBITDA	-0.01	-1.79	-0.09	-0.1	-0.13
Net Debt / EBITDA	4.38	0.95	2.61	2.64	3.02
Total Debt / (EBITDA - Capex)	-0.01	-1.75	-0.09	-0.09	-0.13
Net Debt / (EBITDA - Capex)	4.26	0.93	2.6	2.6	3
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	5.21	27.56	-23.91	-24.72	-36.4
EBITA, 1 Yr. Growth %	5.93	26.49	-22.89	-24.14	-35.62
EBIT, 1 Yr. Growth %	5.97	26.43	-22.8	-24.16	-35.6
Earnings From Cont. Operations, 1 Yr. Growth %	-32.79	109.82	-1.2	-42.99	-36.39
Net Income, 1 Yr. Growth %	-32.79	109.82	-1.2	-42.99	-36.39
Normalized Net Income, 1 Yr. Growth %	-35.91	109.44	-20.88	-28.9	-37.06
Diluted EPS Before Extra, 1 Yr. Growth %	-33.38	104.86	54.87	-64.08	-37.5
Accounts Receivable, 1 Yr. Growth %	525	8	40.74	-136.84	-1.17B
Net Property, Plant and Equip., 1 Yr. Growth %	-22.72	102.98	-29.92	-23.52	-13.52
Total Assets, 1 Yr. Growth %	127.96	-19.24	-25.27	-24.47	-19.94
Tangible Book Value, 1 Yr. Growth %	-22.11	-25.81	121.32	-18.49	-21.09
Common Equity, 1 Yr. Growth %	-21.89	-25.77	119.38	-18.57	-20.37
Cash From Operations, 1 Yr. Growth %	7.57	17.74	-11.19	-37.04	-19.14
Capital Expenditures, 1 Yr. Growth %	5.36	16	-88.53	211.89	-70.93
Levered Free Cash Flow, 1 Yr. Growth %	-	-9.16	-4.33	-44.98	-6.44
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-17.77	31.29	-44.42	-6.61
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	15.85	-1.48	-24.32	-30.81
EBITA, 2 Yr. CAGR %	-	15.75	-1.24	-23.52	-30.12
EBIT, 2 Yr. CAGR %	-	15.75	-1.21	-23.48	-30.11
Earnings From Cont. Operations, 2 Yr. CAGR %	-	18.75	43.98	-24.95	-39.78
Net Income, 2 Yr. CAGR %	-	18.75	43.98	-24.95	-39.78
Normalized Net Income, 2 Yr. CAGR %	-	14.67	28.73	-24.49	-33.8
Diluted EPS Before Extra, 2 Yr. CAGR %	-	16.83	41.43	-25.41	-52.62
Accounts Receivable, 2 Yr. CAGR %	-	159.81	23.29	-27.99	208K
Net Property, Plant and Equip., 2 Yr. CAGR %	-	25.25	19.27	-26.79	-18.68
Total Assets, 2 Yr. CAGR %	-	35.68	-22.31	-24.87	-22.24
Tangible Book Value, 2 Yr. CAGR %	-	-23.98	28.14	34.31	-19.8
Common Equity, 2 Yr. CAGR %	-	-23.85	27.61	33.66	-19.47
Cash From Operations, 2 Yr. CAGR %	-	12.54	2.26	-25.22	-28.65
Capital Expenditures, 2 Yr. CAGR %	-	10.55	-63.53	-40.2	-4.78
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-6.77	-27.45	-28.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	3.9	-14.58	-27.95
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	0.7	-9.93	-28.58
EBITA, 3 Yr. CAGR %	-	-	1.09	-9.56	-27.79
EBIT, 3 Yr. CAGR %	-	-	1.13	-9.54	-27.76
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	11.69	5.73	-28.97
Net Income, 3 Yr. CAGR %	-	-	11.69	5.73	-28.97
Normalized Net Income, 3 Yr. CAGR %	-	-	1.33	6.09	-29.43
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	10.05	-10.43	-29.68
Accounts Receivable, 3 Yr. CAGR %	-	-	111.79	-17.57	18.15K
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	3.21	2.85	-22.61
Total Assets, 3 Yr. CAGR %	-	-	11.22	-23.04	-23.26
Tangible Book Value, 3 Yr. CAGR %	-	-	8.54	10.2	12.49
Common Equity, 3 Yr. CAGR %	-	-	8.35	9.87	12.47
Cash From Operations, 3 Yr. CAGR %	-	-	4	-13.01	-23.25
Capital Expenditures, 3 Yr. CAGR %	-	-	-48.06	-25.42	-52.98
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-21.8	-21.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-15.66	-12
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	-13.34
EBITA, 5 Yr. CAGR %	-	-	-	-	-12.79
EBIT, 5 Yr. CAGR %	-	-	-	-	-12.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	-12.76
Net Income, 5 Yr. CAGR %	-	-	-	-	-12.76
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-14.3
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-21.44
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	3.23K
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-6.17
Total Assets, 5 Yr. CAGR %	-	-	-	-	-3.61
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-3.83
Common Equity, 5 Yr. CAGR %	-	-	-	-	-3.78
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-10.55
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-33.81